BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6333828)

  • 1. Glucocorticoid resistance in depression: the dexamethasone suppression test and lymphocyte sensitivity to dexamethasone.
    Lowy MT; Reder AT; Antel JP; Meltzer HY
    Am J Psychiatry; 1984 Nov; 141(11):1365-70. PubMed ID: 6333828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoid receptors in depression: relationship to the dexamethasone suppression test.
    Gormley GJ; Lowy MT; Reder AT; Hospelhorn VD; Antel JP; Meltzer HY
    Am J Psychiatry; 1985 Nov; 142(11):1278-84. PubMed ID: 4061686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of in vivo and in vitro glucocorticoid sensitivity in depression: relationship to the dexamethasone suppression test.
    Lowy MT; Reder AT; Gormley GJ; Meltzer HY
    Biol Psychiatry; 1988 Oct; 24(6):619-30. PubMed ID: 3262379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-mediated immunity and its glucocorticoid-sensitivity after clinical recovery from severe major depressive disorder.
    Wodarz N; Rupprecht R; Kornhuber J; Schmitz B; Wild K; Riederer P
    J Affect Disord; 1992 May; 25(1):31-8. PubMed ID: 1320638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo and in vitro effects of glucocorticoids on lymphocyte proliferation in depression.
    Rupprecht R; Wodarz N; Kornhuber J; Wild K; Schmitz B; Braner HU; Müller OA; Riederer P; Beckmann H
    Eur Arch Psychiatry Clin Neurosci; 1991; 241(1):35-40. PubMed ID: 1653618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of a study of glucocorticoid receptors in lymphocytes of patients with endogenous depression].
    Pötzsch M; Schütt C; Nitzsche W
    Psychiatr Neurol Med Psychol (Leipz); 1990 Aug; 42(8):479-84. PubMed ID: 2247528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of mitogen concentration on glucocorticoid suppression of normal and cystic fibrosis lymphocyte activation.
    Distelhorst CW; Benutto BM; Corry JM
    Cell Immunol; 1983 Jan; 75(1):188-92. PubMed ID: 6825183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased mitogen-induced lymphocyte proliferation in treatment resistant depression: a preliminary study.
    Kubera M; Basta-Kaim A; Wróbel A; Maes M; Dudek D
    Neuro Endocrinol Lett; 2004 Jun; 25(3):207-10. PubMed ID: 15349087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ACTH administration on bovine polymorphonuclear leukocyte function and lymphocyte blastogenesis.
    Roth JA; Kaeberle ML; Hsu WH
    Am J Vet Res; 1982 Mar; 43(3):412-6. PubMed ID: 6280526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexamethasone suppression in dementia, depression, and normal aging.
    Georgotas A; McCue RE; Kim OM; Hapworth WE; Reisberg B; Stoll PM; Sinaiko E; Fanelli C; Stokes PE
    Am J Psychiatry; 1986 Apr; 143(4):452-6. PubMed ID: 3953888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postdexamethasone prolactin and cortisol: a biological state variable in depression.
    Klein HE; Seibold B; Bender W; Nedopil N; Albus M; Schmauss M
    Acta Psychiatr Scand; 1984 Sep; 70(3):239-47. PubMed ID: 6496148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age and the dexamethasone suppression test in depression.
    Davis KL; Davis BM; Mathé AA; Mohs RC; Rothpearl AB; Levy MI; Gorman LK; Berger P
    Am J Psychiatry; 1984 Jul; 141(7):872-4. PubMed ID: 6731636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Saliva cortisol levels following dexamethasone administration in endogenously depressed patients.
    Poland RE; Rubin RT
    Life Sci; 1982 Jan; 30(2):177-81. PubMed ID: 7054643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum postdexamethasone prolactin measures in depressive patients and control subjects.
    Maes M; Schotte C; Peeters D; D'Hondt P; Martin M; Blockx P; Minner B; Suy E; Cosyns P
    J Psychiatr Res; 1991; 25(3):109-16. PubMed ID: 1941707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal lymphocyte responsiveness to lectins but impaired sensitivity to in vitro glucocorticoids in major depression.
    Wodarz N; Rupprecht R; Kornhuber J; Schmitz B; Wild K; Braner HU; Riederer P
    J Affect Disord; 1991 Aug; 22(4):241-8. PubMed ID: 1658104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of cortisol and lymphocyte subpopulations in depressed and conduct-disordered adolescents.
    Targum SD; Clarkson LL; Magac-Harris K; Marshall LE; Skwerer RG
    J Affect Disord; 1990 Feb; 18(2):91-6. PubMed ID: 2137474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet MAO activity and the dexamethasone suppression test in depressed patients.
    Schatzberg AF; Orsulak PJ; Rothschild AJ; Salomon MS; Lerbinger J; Kizuka PP; Cole JO; Schildkraut JJ
    Am J Psychiatry; 1983 Sep; 140(9):1231-3. PubMed ID: 6614239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dexamethasone suppression test in an elderly population.
    Tourigny-Rivard MF; Raskind M; Rivard D
    Biol Psychiatry; 1981 Dec; 16(12):1177-84. PubMed ID: 6891606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphocyte glucocorticoid receptor binding in depressed patients with hypercortisolemia.
    Schlechte JA; Sherman B
    Psychoneuroendocrinology; 1985; 10(4):469-74. PubMed ID: 4089086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the cortisol suppression index and the dexamethasone suppression test.
    Laux G; Schlesser MA; Rush AJ; Orsulak P; Weissenburger J
    J Clin Psychiatry; 1984 Oct; 45(10):431-2. PubMed ID: 6480568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.